Pfizer New Corona Vaccine Apply for permission in late November October 17, 4:59
Pfizer, a major US pharmaceutical company, said it expects to apply for an emergency use permit from regulators in late November if the new coronavirus vaccine under development is confirmed to be effective.
Pfizer, a major American pharmaceutical company, is developing a vaccine with a German company and is currently in the final stage of a third-stage clinical trial.
On the 16th, Pfizer CEO Bula issued a statement about the outlook for future development, saying that "it is important to carefully verify the effectiveness and safety, and to achieve high quality in the manufacturing process". He said he aims to meet the three conditions of quality.
He said, "We will know if the vaccine is effective at the end of this month." If the effect is confirmed, it will be urgent to the US FDA = Food and Drug Administration after the third week of November when safety data will be available. The prospect of applying for permission to use has been revealed.
Pfizer's vaccine is one of the most developed vaccines, and with this announcement, the practical application of the vaccine before the presidential election, which President Trump of the United States has repeatedly mentioned, is becoming more difficult.